Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v3-EN
Language French English
Date Updated 2021-04-26 2021-02-25
Drug Identification Number 02486717 02486717
Brand name AMIKACIN SULFATE INJECTION AMIKACIN SULFATE INJECTION
Common or Proper name Amikacin Sulfate Injection Amikacin Sulfate Injection
Company Name OMEGA LABORATORIES LIMITED OMEGA LABORATORIES LIMITED
Ingredients AMIKACIN AMIKACIN
Strength(s) 250MG 250MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 10 x 2mL vial / fiole 10 x 2mL vial / fiole
ATC code J01GB J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2020-10-23 2020-10-23
Estimated end date 2021-04-06 2021-04-06
Actual end date 2021-04-12
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Demand on the market. Demand on the market.
Health Canada comments